Scaling/Commercialization

Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss commercial readiness of biotechs

Scaling/Commercialization

Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?

Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss the commercial readiness of biotechs, and tackle some hard challenges and myths around dealmaking in the ecosystem.

byBIO-Europe 2024

Dec 18, 2024

|

9 Min View

@Informa BIO-Europe 2024, CEO of Cellevate interview

Scaling/Commercialization

Scale Up and Boost Your Viral Vector Production Scale Up and Boost Your Viral Vector Production

byBIO-Europe 2024

Dec 17, 2024

4 Min View

Plenary at BIO-Europe in Munich

How industry trends are evolving biotech innovation in 2023 2023 industry trends that helped evolve biotech innovation

Sep 21, 2024

1 Min Read

CEO of Poseida, Kristin Yarema

Business Strategy

Poseida: New CEO, same passion for allogeneic therapies Poseida: New CEO, same passion for allogeneic therapies

byMillie Nelson

Feb 26, 2024

1 Min Read

It’s not me, it’s you! Experts on when you should dump your CDMO Experts on when you should dump your CDMO

byMillie Nelson

Sep 22, 2023

1 Min Read

Note with politics written on it

Business Strategy

Patient access is political, say CGT experts Patient access is political, say CGT experts

byMillie Nelson

Jan 9, 2023

1 Min Read

Subscribe to Our Newsletters

Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.